Used in research settings to quantify trypsinogen activation peptide (TAP) in biological samples, aiding in the study of pancreatic function and trypsin activation pathways. Helps investigate conditions like acute pancreatitis, where premature trypsinogen activation occurs. Enables monitoring of disease progression and evaluation of therapeutic interventions in experimental models. Commonly applied in preclinical studies involving mouse models to assess pancreatic injury and inflammation. Supports biomarker validation and drug development research targeting protease activity.